Skip to content
The Times USA
Menu
  • ABOUT
  • CONTACT
  • LIFESTYLE
  • NATIONAL NEWS
  • BUSINESS
  • INTERNATIONAL NEWS
  • TECHNOLOGY
  • PRICE OF BUSINESS SHOW AUDIOS
Menu

Group Seeks to Radically Change the Business Model of the Pharmaceutical Industry

Posted on January 16, 2019January 14, 2019 by admin

Achieving the full societal benefits of curing chronic or life-threatening diseases will remain an elusive goal unless the pharmaceutical industry changes its economic model, according to new report by Boston Consulting Group (BCG). The report, titled Aligning Economic Incentives to Eradicate Diseases, was recently released.

The study recommends that the industry replace its current economic model, which calls for charging by treatment at the time of care, with a licensing model that is based on the entire affected population. BCG’s new approach, the payer licensing agreement (PLA), is analogous to models used by major software and media companies. When BCG tested the PLA against the current economic model for cures for the hepatitis C virus (HCV), the analysis showed that the PLA could achieve the following:

  • Triple the number of patients treated and cured within two years
  • Reduce the number of liver-related deaths by some 60%
  • Reduce the total cost to payers by approximately 30%, because patients would be treated much earlier—before the disease progresses to more costly stages
  • Provide higher and more predictable revenues and profits to pharmaceutical manufacturers

“Current economic models in the pharmaceutical industry are well designed to manage diseases, not cure them,” said Jean-Manuel Izaret, a BCG senior partner and coauthor of the study. “The solution is to price the cures on the basis of the total population rather than individual patients.”

BCG’s epidemiological and economic modeling of HCV treatment, performed in collaboration with the Center for Disease Analysis, showed that, in every market tested, patients, payers, and pharmaceutical companies would do better under a PLA.

The PLA Solves a Frustrating Dilemma 
The authors chose HCV as their test case because the disease remains a global crisis. Despite the introduction of innovative cures in 2013, more than 90% of the world’s infected population (71 million) remains uncured, a far cry from the World Health Organization’s target of eradication by 2030.

“There are many barriers to curing this population, but the dilemma created by current pricing models is one of the biggest,” said Dave Matthews, a BCG principal and study coauthor. The dilemma results because a high price per patient makes treating everyone prohibitively expensive while an affordable price is too low for pharmaceutical companies to earn back their investments.

“Switching to a population-based model such as the PLA not only makes the cure affordable, but also creates strong motivation to identify, diagnose, and treat as many patients as possible before the license expires,” Matthews explained.

Looking Beyond HCV to Curing Other Diseases
HCV serves as a robust test case, but BCG views the PLA as an attractive model for other cures as well. “We are convinced that the PLA model could be beneficial from health care, social, and economic standpoints as pharmaceutical companies bring other cures to market,” said Mark Lubkeman, a BCG senior partner and one of the study’s coauthors.

You Might Also Like...

  • Iconic Business Magazine Brand Sold for $150 Million

    Meredith Corporationtoday announced an agreement to sell the FORTUNE media brand for $150 million cash…

  • Small Business Job Growth Slowed at the End of 2018

    The Paychex | IHS Markit Small Business Employment Watch closed the year with a decline in…

  • Very Large Breaches

    By the Price of Business Show, Hosted by Kevin Price.  The Price of Business is a media…

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

VIDEO: This Week’s Best of our Network

https://www.youtube.com/watch?v=lxPSbUATgF8

GDPR Compliance

USABR does not collect data on its visitors.  For more information visit: https://www.usabusinessradio.com/contact-us/

Contact

Contact articles@usabusinessradio.net for more information on articles on this site. BMuyco@usabusinessradio.net for all other information.

Recent Articles

  • Fuel Management Strategies for Multi-Vehicle Fleets
  • PR Is Still Key for Growing Companies, but It’s Changed
  • How QA and Cybersecurity Combine To Build Trustworthy Digital Products
  • A Strategic Approach to Succession Planning: Maintaining Your Corporate Culture and Operational Efficiency During a Succession
  • Leadership Flow

Also in TTUSA

  • Content Strategy In The New Normal- How Businesses Need To Realign
  • How to Build and Leverage Facebook Patient Relationships
  • Patrick Van Negri Has Publicized a Project to Deliver Free Masks from Miami
  • In Spite Concerns, Manufacturing Industry Remains Optimistic
  • Type 2 Diabetes 

RSS The Daily Blaze

  • Intuition Is Deeper With More To Give Than We Think
  • Leading Tariff Authority Provides Preview of Federal Court Upcoming Decision on Trump’s “Liberation Day” Tariffs
  • The Dirty Secrets of the Insurance Industry
  • Frivolous Lawsuits Undercut Press Freedom
  • Tragedy in Flash Flood Alley: A Wake-Up Call for Government Preparedness

RSS USA Business Radio

  • Obtaining Maximum Recovery From Property Damages
  • A Holistic Approach to Federal White Collar Criminal Defense
  • What Media Exposure Actually Does for a Business
  • Need Help Navigating Long Term Care? Start With Your Long Term Care Insurance Specialist
  • Knowing Your Worth in PR

RSS USA Daily Times

  • Understanding the Grieving Brain
  • Luxury Travel as a High-Impact Investment
  • The Smartest Way To Scale ServiceNow: People, Not Just Platform
  • Where Price Meets Prestige: A First-Class Travel Experience
  • Luxury Travel in Hawaii and the South Pacific

RSS USA Daily Chronicles.

  • Fortify Your Front Door With the Right Lock
  • David H. Souter, Retired U.S. Supreme Court Justice, Dies at 85
  • 3 Enlightened Things You Need To Know if You Feel Like You’re Losing Your Mind
  • Let’s Prevent Child Abuse Every Month
  • Bringing Resilience and Simplicity Into Life With MS

RSS Price of Business

  • “Trading Platforms” and more on PriceofBusiness.com: Latest Guest Posts & Articles for July 16th 2025
  • Pioneering New Persuasion Pathways With Innovative E-Commerce Merchandising
  • TradeGaia vs the Rest: My Verdict After Testing 10+ Trading Platforms
  • Understanding the Grieving Brain
  • Leading Tariff Authority Provides Preview of Federal Court Upcoming Decision on Trump’s “Liberation Day” Tariffs

RSS US Daily Review

  • Leading Business Authority Answers Listeners Questions on Navigating Tariffs
  • Jenny Lyon’s Commentary Feature on the Price of Business Digital Network
  • Promise and Pushback: The Debate Over the Big Beautiful Bill
  • What’s the Deal With Musk’s “America Party?”
  • The Fit That Matters

PoB Digital Network

US Daily Review

USA Business Radio

USA Daily Chronicles

USA Daily Times

The Daily Blaze

The Times USA

Price of Business

© 2025 The Times USA | Powered by Superbs Personal Blog theme